FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965742829> ?p ?o ?g. }

• W1965742829 endingPage "283" @default.
• W1965742829 startingPage "283" @default.
• W1965742829 abstract "Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring Shinya Abe1,2, Gaku Inoue1,2, Satoru Yamada1,3, Junichiro Irie1,3, Hiroyuki Nojima2, Kaoru Tsuyusaki2, Kensuke Usui2, Koichiro Atsuda2, Toshikazu Yamanouchi41Diabetes Center, Kitasato Institute Hospital, 2Center for Clinical Pharmacy and Clinical Sciences, Kitasato University, 3Department of Internal Medicine, Keio University School of Medicine, 4Department of Internal Medicine, University of Teikyo School of Medicine, Tokyo, JapanObjective: This study aimed to compare the glucose-lowering effect and glycemic variability of insulin glargine with those of insulin detemir.Material and methods: This was an open-label, single-center, randomized, two-way crossover study in patients with diabetes on basal-bolus insulin therapy, with neutral protamine Hagedorn (NPH) insulin as basal insulin. Patients switched from NPH insulin to a course either of insulin glargine followed by insulin detemir, or insulin detemir followed by insulin glargine, continuing the same dose of the prior bolus of insulin. To evaluate the glucose-lowering effect, daily glycemic profiles were recorded for 72 hours by continuous glucose monitoring (CGM) in an outpatient setting. The mean amplitude of glycemic excursions, standard deviation (SD), and the mean of daily difference (MODD) were used to assess intraday and day-to-day glycemic variability.Results: Eleven patients were enrolled and nine completed the study. Mean blood glucose calculated from CGM values was significantly lower with insulin glargine compared with insulin detemir (9.6 ± 2.4 mmol/L versus 10.4 ± 2.8 mmol/L, P = 0.038). The SD was significantly lower with insulin glargine versus insulin detemir (2.5 ± 0.9 mmol/L vs 3.5 ± 1.6 mmol/L, P = 0.011). The MODD value was significantly lower with insulin glargine than with insulin detemir (2.2 ± 1.1 mmol/L vs 3.6 ± 1.7 mmol/L, P = 0.011). There was no significant difference between the two insulin analogs in terms of hypoglycemia.Conclusion: This study suggests that insulin glargine leads to more effective and more stable glycemic control than the same dose of insulin detemir.Keywords: continuous glucose monitoring, insulin detemir, insulin glargine&nbsp" @default.
• W1965742829 created "2016-06-24" @default.
• W1965742829 creator A5002445778 @default.
• W1965742829 creator A5006115160 @default.
• W1965742829 creator A5018251057 @default.
• W1965742829 creator A5031860075 @default.
• W1965742829 creator A5038590404 @default.
• W1965742829 creator A5040458916 @default.
• W1965742829 creator A5052830943 @default.
• W1965742829 creator A5076538538 @default.
• W1965742829 creator A5085978342 @default.
• W1965742829 date "2011-07-01" @default.
• W1965742829 modified "2023-09-30" @default.
• W1965742829 title "Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring" @default.
• W1965742829 cites W145990486 @default.
• W1965742829 cites W1856293447 @default.
• W1965742829 cites W1966463574 @default.
• W1965742829 cites W1990478724 @default.
• W1965742829 cites W2008673024 @default.
• W1965742829 cites W2018012924 @default.
• W1965742829 cites W2019136020 @default.
• W1965742829 cites W2043324706 @default.
• W1965742829 cites W2058777107 @default.
• W1965742829 cites W2070859585 @default.
• W1965742829 cites W2071173797 @default.
• W1965742829 cites W2078089300 @default.
• W1965742829 cites W2079089745 @default.
• W1965742829 cites W2081135787 @default.
• W1965742829 cites W2084807176 @default.
• W1965742829 cites W2108747912 @default.
• W1965742829 cites W2119217129 @default.
• W1965742829 cites W2122994980 @default.
• W1965742829 cites W2127521907 @default.
• W1965742829 cites W2130931445 @default.
• W1965742829 cites W2133807304 @default.
• W1965742829 cites W2136164787 @default.
• W1965742829 cites W2137415633 @default.
• W1965742829 cites W2138112294 @default.
• W1965742829 cites W2139425593 @default.
• W1965742829 cites W2145562665 @default.
• W1965742829 cites W2158144637 @default.
• W1965742829 cites W2769264260 @default.
• W1965742829 doi "https://doi.org/10.2147/dmso.s21513" @default.
• W1965742829 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3139536" @default.
• W1965742829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21792327" @default.
• W1965742829 hasPublicationYear "2011" @default.
• W1965742829 type Work @default.
• W1965742829 sameAs 1965742829 @default.
• W1965742829 citedByCount "4" @default.
• W1965742829 countsByYear W19657428292014 @default.
• W1965742829 countsByYear W19657428292015 @default.
• W1965742829 countsByYear W19657428292016 @default.
• W1965742829 crossrefType "journal-article" @default.
• W1965742829 hasAuthorship W1965742829A5002445778 @default.
• W1965742829 hasAuthorship W1965742829A5006115160 @default.
• W1965742829 hasAuthorship W1965742829A5018251057 @default.
• W1965742829 hasAuthorship W1965742829A5031860075 @default.
• W1965742829 hasAuthorship W1965742829A5038590404 @default.
• W1965742829 hasAuthorship W1965742829A5040458916 @default.
• W1965742829 hasAuthorship W1965742829A5052830943 @default.
• W1965742829 hasAuthorship W1965742829A5076538538 @default.
• W1965742829 hasAuthorship W1965742829A5085978342 @default.
• W1965742829 hasBestOaLocation W19657428291 @default.
• W1965742829 hasConcept C126322002 @default.
• W1965742829 hasConcept C134018914 @default.
• W1965742829 hasConcept C142724271 @default.
• W1965742829 hasConcept C204787440 @default.
• W1965742829 hasConcept C27081682 @default.
• W1965742829 hasConcept C2778024521 @default.
• W1965742829 hasConcept C2778804033 @default.
• W1965742829 hasConcept C2779306644 @default.
• W1965742829 hasConcept C2779920387 @default.
• W1965742829 hasConcept C2780473172 @default.
• W1965742829 hasConcept C2780668416 @default.
• W1965742829 hasConcept C2780677441 @default.
• W1965742829 hasConcept C2986379492 @default.
• W1965742829 hasConcept C43376680 @default.
• W1965742829 hasConcept C555293320 @default.
• W1965742829 hasConcept C71924100 @default.
• W1965742829 hasConcept C87813604 @default.
• W1965742829 hasConcept C90924648 @default.
• W1965742829 hasConceptScore W1965742829C126322002 @default.
• W1965742829 hasConceptScore W1965742829C134018914 @default.
• W1965742829 hasConceptScore W1965742829C142724271 @default.
• W1965742829 hasConceptScore W1965742829C204787440 @default.
• W1965742829 hasConceptScore W1965742829C27081682 @default.
• W1965742829 hasConceptScore W1965742829C2778024521 @default.
• W1965742829 hasConceptScore W1965742829C2778804033 @default.
• W1965742829 hasConceptScore W1965742829C2779306644 @default.
• W1965742829 hasConceptScore W1965742829C2779920387 @default.
• W1965742829 hasConceptScore W1965742829C2780473172 @default.
• W1965742829 hasConceptScore W1965742829C2780668416 @default.
• W1965742829 hasConceptScore W1965742829C2780677441 @default.
• W1965742829 hasConceptScore W1965742829C2986379492 @default.
• W1965742829 hasConceptScore W1965742829C43376680 @default.
• W1965742829 hasConceptScore W1965742829C555293320 @default.
• W1965742829 hasConceptScore W1965742829C71924100 @default.
• W1965742829 hasConceptScore W1965742829C87813604 @default.

• next